Increased endothelin receptor B and G protein coupled kinase-2 in the mesentery of portal hypertensive rats

World Journal of Gastroenterology

Volumn 19, Issue 13, 2013, Pages 2065-2072

  Du, Qing Hong ^a   Han, Lin ^a   Jiang, Jun Jie ^a   Li, Peng Tao ^a   Wang, Xin Yue ^a   Jia, Xu ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Endothelin; Endothelin B receptor; G protein coupled kinase 2; Mesentery; Portal hypertension

Indexed keywords

BETA ARRESTIN 2; CD31 ANTIGEN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; IMMUNOFLUORESCENCE TEST; MALE; MESENTERY BLOOD FLOW; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RADIOIMMUNOPRECIPITATION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84876380865     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i13.2065     Document Type: Article

References (29)

1. Rössle M. Hyperdynamic circulation and portal hypertension: chicken or egg? Gut 2011; 60: 1167-1169. [PMID: 21613646 DOI: 10.1136/gut.2011.242511]
2. Angus PW. Role of endothelin in systemic and portal resistance in cirrhosis. Gut 2006; 55: 1230-1232. [PMID: 16905694 DOI: 10.1136/gut.2005.088633]
3. Braillon A, Lee SS, Girod C, Peignoux-Martinot M, Valla D, Lebrec D. Role of portasystemic shunts in the hyperkinetic circulation of the portal hypertensive rat. J Lab Clin Med 1986; 108: 543-548. [PMID: 3783027]
4. Pateron D, Tazi KA, Sogni P, Heller J, Chagneau C, Poirel O, Philippe M, Moreau R, Lebrec D. Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilation of portal hypertension. Gastroenterology 2000; 119: 196-200. [PMID: 10889169 DOI: 10.1053/gast.2000.8554]
5. Blendis L, Wong F. The hyperdynamic circulation in cirrhosis: an overview. Pharmacol Ther 2001; 89: 221-231. [PMID: 11516477 DOI: 1016/S0163-7258(01)00124-3]
6. Rockey DC, Fouassier L, Chung JJ, Carayon A, Vallee P, Rey C, Housset C. Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells. Hepatology 1998; 27: 472-480. [PMID: 9462646 DOI: 10.1002/hep.510270222]
7. Rockey DC. Vascular mediators in the injured liver. Hepatology 2003; 37: 4-12. [PMID: 12500181 DOI: 10.1053/jhep.2003. 50044]
8. Tièche S, De Gottardi A, Kappeler A, Shaw S, Sägesser H, Zimmermann A, Reichen J. Overexpression of endothelin-1 in bile duct ligated rats: correlation with activation of hepatic stellate cells and portal pressure. J Hepatol 2001; 34: 38-45. [PMID: 11211905 DOI: 10.1016/S0168-8278(00)00031-3]
9. Degertekin B, Ozenirler S, Elbeg S, Akyol G. The serum endothelin-1 level in steatosis and NASH, and its relation with severity of liver fibrosis. Dig Dis Sci 2007; 52: 2622-2628. [PMID: 17429733 DOI: 10.1007/s10620-006-9147-8]
10. Mallat A, Lotersztajn S. Multiple hepatic functions of endothelin-1: physiopathological relevance. J Hepatol 1996; 25: 405-413. [PMID: 8895023 DOI: 10.1016/S0168-8278(96)801 30-9]
11. Sakurai T, Yanagisawa M, Masaki T. Molecular characterization of endothelin receptors. Trends Pharmacol Sci 1992; 13: 103-108. [PMID: 1315462]
12. Clozel M, Gray GA, Breu V, Löffler BM, Osterwalder R. The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun 1992; 186: 867-873. [PMID: 1323294 DOI: 10.1016/0006-291X(92)908 26-7]
13. Battistini B, D'Orléans-Juste P, Sirois P. Endothelins: circulating plasma levels and presence in other biologic fluids. Lab Invest 1993; 68: 600-628. [PMID: 8515652]
14. Leivas A, Jiménez W, Lamas S, Bosch-Marcé M, Oriola J, Clària J, Arroyo V, Rivera F, Rodés J. Endothelin 1 does not play a major role in the homeostasis of arterial pressure in cirrhotic rats with ascites. Gastroenterology 1995; 108: 1842-1848. [PMID: 7768391 DOI: 10.1016/0016-5085(95)90148-5]
15. Helmy A, Newby DE, Jalan R, Hayes PC, Webb DJ. Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide. Gut 2003; 52: 410-415. [PMID: 12584225 DOI: 10.1136/gut.52. 3.410]
16. Luo B, Liu L, Tang L, Zhang J, Stockard CR, Grizzle WE, Fallon MB. Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: a potential mechanism in experimental hepatopulmonary syndrome. J Hepatol 2003; 38: 556-563. [PMID: 12713865 DOI: 10.1016/S0168-8278(03)00012-6]
17. Tang L, Luo B, Patel RP, Ling Y, Zhang J, Fallon MB. Modulation of pulmonary endothelial endothelin B receptor expression and signaling: implications for experimental hepatopulmonary syndrome. Am J Physiol Lung Cell Mol Physiol 2007; 292: L1467-L1472. [PMID: 17337507 DOI: 10.1152/ajplung. 00446.2006]
18. Ling Y, Zhang J, Luo B, Song D, Liu L, Tang L, Stockard CR, Grizzle WE, Ku DD, Fallon MB. The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat. Hepatology 2004; 39: 1593-1602. [PMID: 15185300 DOI: 10.1002/hep.20244]
19. Vashist Y, Semela D, Dufour JF. Hyperdynamic circulation in liver cirrhosis: desensitization of vasoconstrictive receptors by G protein-coupled receptor kinases. Med Hypotheses 2004; 62: 82-85. [PMID: 14729009 DOI: 10.1016/S0306-9877 (03)00311-6]
20. Gurevich EV, Tesmer JJ, Mushegian A, Gurevich VV. G pro tein-coupled receptor kinases: more than just kinases and not only for GPCRs. Pharmacol Ther 2012; 133: 40-69. [PMID: 21903131 DOI: 10.1016/j.pharmthera.2011.08.001]
21. Freedman NJ, Ament AS, Oppermann M, Stoffel RH, Exum ST, Lefkowitz RJ. Phosphorylation and desensitization of human endothelin A and B receptors. Evidence for G proteincoupled receptor kinase specificity. J Biol Chem 1997; 272: 17734-17743. [PMID: 9211925 DOI: 10.1074/jbc.272.28.17734]
22. Morris GE, Nelson CP, Standen NB, Challiss RA, Willets JM. Endothelin signalling in arterial smooth muscle is tightly regulated by G protein-coupled receptor kinase 2. Cardiovasc Res 2010; 85: 424-433. [PMID: 19748906 DOI: 10.1093/cvr/ cvp310]
23. Oakley RH, Laporte SA, Holt JA, Caron MG, Barak LS. Diffe rential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J Biol Chem 2000; 275: 17201-17210. [PMID: 10748214 DOI: 10.1074/jbc.M910348199]
24. Hennenberg M, Trebicka J, Biecker E, Schepke M, Sauerbruch T, Heller J. Vascular dysfunction in human and rat cirrhosis: role of receptor-desensitizing and calcium-sensitizing proteins. Hepatology 2007; 45: 495-506. [PMID: 17256744 DOI: 10.1002/hep.21502]
25. Cichoz-Lach H, Celiński K, Słomka M, Kasztelan-Szczer bińska B. Pathophysiology of portal hypertension. J Physiol Pharmacol 2008; 59 Suppl 2: 231-238. [PMID: 18812641]
26. Lebrec D, Bosch J, Jalan R, Dudley FJ, Jessic R, Moreau R, Garcia-Pagan JC, Mookerjee RP, Chiossi E, Van Giersbergen PL, Kusic-Pajic A, Dingemanse J. Hemodynamics and pharmacokinetics of tezosentan, a dual endothelin receptor antagonist, in patients with cirrhosis. Eur J Clin Pharmacol 2012; 68: 533-541. [PMID: 22101624 DOI: 10.1007/s00228-011-1157-6]
27. Tripathi D, Therapondos G, Ferguson JW, Newby DE, Webb DJ, Hayes PC. Endothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial. Gut 2006; 55: 1290-1295. [PMID: 16434427 DOI: 10.1136/gut.2005.077453]
28. Reiter E, Lefkowitz RJ. GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol Metab 2006; 17: 159-165. [PMID: 16595179 DOI: 10.1016/ j.tem.2006.03.008]
29. Ribas C, Penela P, Murga C, Salcedo A, García-Hoz C, Jurado-Pueyo M, Aymerich I, Mayor F. The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. Biochim Biophys Acta 2007; 1768: 913-922. [PMID: 17084806 DOI: 10.1016/j.bbamem.2006.09.019]